About US
Contact us
-
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfiresIn the aftermath of devastating wildfires on Maui, Bayer is standing up as one of the first pharmaceutical companies to offer relief. The German conglomerate isprovidinga cash donation of2023/7/28
-
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmaciesAs companies have flocked to compete in the new respiratory syncytial virus (RSV) vaccine market, GSK has had the best timing. In May, the U.K. company was first tosecure2023/7/28
-
GSK yanks 2 batches of its asthma blockbuster Nucala in Taiwan over glass particle fearsIn the world of drug packaging, a vial is a vial, the product the product, and never the twain shall meet. When those standards start to slip, recalls are sure to follow. No2023/7/24
-
UK's Upperton wraps up £15M manufacturing expansion projectUpperton Pharma Solutions, a U.K.-based CDMO,put the finishing toucheson a 15 million pound sterling ($19.6 million) expansionof its manufacturing facility near its headquarters in Nottingham. Wit2023/7/24
-
Catalent's Indiana site, linked with Regeneron's high-dose Eylea rejection, dinged with 3 FDA observationsAfter Regeneron’s high-dose Eylea received a surprising FDA snub, the FDA disclosed cleaning and procedural issues at Catalent, the manufacturer linked with the rejection. Regeneronattributedthe r2023/7/20
-
MilliporeSigma earmarks $25M to expand dry powder cell operationsMilliporeSigma, Merck KGaA’s life science arm, plans to spend $25 millionas part of an expansion project at its dry powder cell culture media facility in the Kansas City suburb of Lenexa, Kansas.2023/7/20
-
Lupin gets off light after FDA inspection at Indian manufacturing plantLupin is no stranger to FDA rebukes, though its latest write-up from the U.S. drug regulator certainly could have been worse for the company. Following an inspection of Lupin’s Pithampur Unit-2 ma2023/7/18
-
FDA clears more chemotherapy imports from China's Qilu amid shortage of key cancer medsAs a shortage of key chemotherapy drugs continues to upend cancer treatment across the country, the FDA has resorted to securing some of the meds from China. After approving2023/7/18
-
FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concernsWith Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely. That’s good news for Bristol Myers Squibb, which has secured a few m2023/7/13
-
Samsung Biologics, after expanding Pfizer collab, inks Novartis production deal worth $391MSamsung Biologics, after expanding Pfizer collab, inks Novartis production deal worth $391MJust days after sewing up a pair of $897 million deals with Pfizer, Samsung Biologics has added a few hundred million dollars more to its partnership cash pile—this time courtesy of an expanded pact2023/7/13